Balchem Balance Sheet Health

Financial Health criteria checks 4/6

Balchem has a total shareholder equity of $1.1B and total debt of $309.6M, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are $1.6B and $543.2M respectively. Balchem's EBIT is $156.9M making its interest coverage ratio 6.9. It has cash and short-term investments of $64.4M.

Key information

29.4%

Debt to equity ratio

US$309.57m

Debt

Interest coverage ratio6.9x
CashUS$64.45m
EquityUS$1.05b
Total liabilitiesUS$543.23m
Total assetsUS$1.60b

Recent financial health updates

Recent updates

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Mar 21
Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Mar 05
Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Balchem: Potential Turnaround Is In The Price

Feb 21

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Feb 18
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Jan 03
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Dec 19
Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Nov 20
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Oct 19
Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Sep 09
The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 22
A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Jul 19
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

May 28
Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Apr 12
Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Mar 14
We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Jan 11
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Dec 29
Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Dec 13
Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Nov 29
Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Sep 20
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Acquisitions And Cost Pressures Draw Attention

Sep 12

Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Sep 05
Balchem (NASDAQ:BCPC) Seems To Use Debt Rather Sparingly

Balchem to acquire Cardinal Associates or Bergstrom Nutrition

Aug 30

Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Aug 22
Is Balchem Corporation (NASDAQ:BCPC) Worth US$138 Based On Its Intrinsic Value?

Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Aug 08
Should You Be Adding Balchem (NASDAQ:BCPC) To Your Watchlist Today?

Balchem Q2 2022 Earnings Preview

Jul 28

Balchem: On The M&A Road Again

Jun 28

Balchem: A New Growth Stage Is Just Beginning

Jun 02

Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

May 30
Slowing Rates Of Return At Balchem (NASDAQ:BCPC) Leave Little Room For Excitement

Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

May 18
Balchem Corporation's (NASDAQ:BCPC) Intrinsic Value Is Potentially 17% Below Its Share Price

Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

May 02
Does Balchem (NASDAQ:BCPC) Deserve A Spot On Your Watchlist?

Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Mar 28
Does Balchem (NASDAQ:BCPC) Have A Healthy Balance Sheet?

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Feb 26
Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Dec 23
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Nov 18
Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Sep 22
We Think Balchem (NASDAQ:BCPC) Can Manage Its Debt With Ease

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Aug 16
Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Good Quarterly Performance Priced In

Aug 02

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 12
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

May 13
Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Balchem EPS beats by $0.03, beats on revenue

Apr 30

Balchem: All Eyes On M&A And Autism Drug

Apr 26

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Mar 14
Is Balchem (NASDAQ:BCPC) A Risky Investment?

How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?

Feb 27
How Many Balchem Corporation (NASDAQ:BCPC) Shares Have Insiders Sold, In The Last Year?

Financial Position Analysis

Short Term Liabilities: BCPC's short term assets ($314.2M) exceed its short term liabilities ($148.5M).

Long Term Liabilities: BCPC's short term assets ($314.2M) do not cover its long term liabilities ($394.7M).


Debt to Equity History and Analysis

Debt Level: BCPC's net debt to equity ratio (23.3%) is considered satisfactory.

Reducing Debt: BCPC's debt to equity ratio has increased from 22.6% to 29.4% over the past 5 years.

Debt Coverage: BCPC's debt is well covered by operating cash flow (59.4%).

Interest Coverage: BCPC's interest payments on its debt are well covered by EBIT (6.9x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.